|
Market Closed -
Nasdaq
20:00:00 29/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 4.400 USD | -9.09% |
|
-6.98% | -57.20% |
| Market Cap | 159M 142M 131M 119M 222M 15.11B 225M 1.56B 624M 7.91B 595M 583M 25.04B | P/E 2026 * |
-1.1x | P/E 2027 * | -1.22x |
|---|---|---|---|---|---|
| Enterprise Value | 129M 115M 106M 96.11M 180M 12.24B 183M 1.27B 505M 6.41B 482M 472M 20.29B | EV / Sales 2026 * |
10.6x | EV / Sales 2027 * | -5.27x |
| Free-Float |
85.81% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TRDA | Delayed | |
CBOE
| TRDA | Real-time |
Last Transcript: Entrada Therapeutics, Inc.
| 20/12/22 | Nipte winst op Wall Street | |
| 20/12/22 | Wall Street licht hoger | |
| 20/12/22 | Wall Street richting rode opening |
| 1 day | -9.09% | ||
| 1 week | -6.98% | ||
| Current month | -30.71% | ||
| 1 month | -29.71% | ||
| 3 months | -32.82% | ||
| 6 months | -65.41% | ||
| Current year | -57.20% |
| 1 week | 4.33 |  | 5.07 |
| 1 month | 4.11 | | 6.36 |
| Current year | 4.11 | | 16.45 |
| 1 year | 4.11 | | 16.45 |
| 3 years | 4.11 | | 21.79 |
| 5 years | 4.11 | | 36.85 |
| 10 years | 4.11 | | 36.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dipal Doshi
CEO | Chief Executive Officer | 50 | 31/07/2017 |
Kory Wentworth
DFI | Director of Finance/CFO | 47 | 31/10/2020 |
Nathan Dowden
PSD | President | 56 | 31/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Dipal Doshi
BRD | Director/Board Member | 50 | 31/07/2017 |
Kush Parmar
CHM | Chairman | 45 | 30/11/2020 |
Peter Kim
BRD | Director/Board Member | 67 | 30/11/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 09/09/26 | MPM BioImpact LLC
| Sell | Company | -28,837 | 0.0741% | |
| 09/09/26 | MPM BioImpact LLC
| Sell | Company | -28,837 | 0.0741% | |
| 03/09/26 | MPM BioImpact LLC
| Sell | Company | -32,263 | 0.0829% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -9.09% | -6.98% | -36.14% | -69.66% | 159M | |
| +0.34% | +1.12% | +34.75% | +61.06% | 64.38B | |
| -0.07% | +2.74% | +14.41% | +83.72% | 56.16B | |
| +1.06% | +2.66% | +16.15% | +108.22% | 54.16B | |
| -1.43% | -1.17% | +26.27% | +52.86% | 45.33B | |
| -0.48% | -2.80% | +18.01% | +117.99% | 42.25B | |
| +0.82% | +1.37% | +227.94% | +922.41% | 40.78B | |
| +1.32% | +45.23% | +108.75% | +92.87% | 33.8B | |
| -0.26% | -2.57% | +12.55% | +45.18% | 32.25B | |
| -1.29% | -2.88% | +21.60% | -11.92% | 23.57B | |
| Average | -0.74% | +3.35% | +44.43% | +140.27% | 39.28B | |
| Weighted average by Cap. | +0.27% | +3.59% | +50.28% | +162.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 12.17M 10.9M 10.06M 9.1M 17.02M 1.16B 17.29M 120M 47.87M 607M 45.67M 44.7M 1.92B | 22.86M 20.48M 18.89M 17.1M 31.97M 2.18B 32.49M 225M 89.93M 1.14B 85.81M 83.98M 3.61B |
| Net income | -174M -156M -144M -130M -244M -16.6B -248M -1.72B -686M -8.69B -654M -640M -27.52B | -184M -165M -152M -138M -258M -17.56B -262M -1.82B -725M -9.19B -692M -677M -29.11B |
| Net Debt | -30.12M -26.98M -24.89M -22.53M -42.12M -2.87B -42.8M -297M -118M -1.5B -113M -111M -4.75B | -279M -250M -231M -209M -390M -26.58B -397M -2.75B -1.1B -13.91B -1.05B -1.03B -44.05B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | US$4.400 | -9.09% | 479,056 |
| 28/10/26 | US$4.840 | +9.75% | 409,095 |
| 27/10/26 | US$4.410 | -7.16% | 413,454 |
| 26/10/26 | US$4.750 | +7.71% | 617,087 |
| 23/10/26 | US$4.410 | -6.77% | 191,471 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TRDA Stock
Select your edition
All financial news and data tailored to specific country editions
